ATLASAmgen (AMGN) earnings date: Nov 3, 2026
Amgen (AMGN) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of $5.74.
Source: company filings and exchange data · Updated Nov 2, 2026
Amgen reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Amgen. You can switch it off at any time.
Alert me before AMGN reportsFree to start. Creating an account takes under a minute.
AMGN earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $5.74 |
| Last report | Aug 4, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +23.4% |
| Average move around a report | ±5.9% (last 5) |
| Sector | Healthcare · Drug Manufacturers - General |
Amgen earnings history: last 5 reports
Amgen last reported on Aug 4, 2026: EPS of $6.29 against an estimate of $5.62 (+11.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | $5.62 | $6.29 | +11.9% | Beat | +7.6% |
| Jun 11, 2026 | -$0.33 | -$0.09 | +72.7% | Beat | +5.2% |
| Apr 30, 2026 | $4.77 | $5.15 | +8.0% | Beat | -2.4% |
| Feb 3, 2026 | $4.73 | $5.29 | +11.8% | Beat | +6.2% |
| Nov 4, 2025 | $5.01 | $5.64 | +12.6% | Beat | +8.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on AMGN before the report
| Last price | $466.01 (+1.2%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 51% |
| Likely 1-month range (50%) | $444.95 – $490.51 |
| Normal 1-day range (±1σ) | ±1.7% |
| ATLAS fair value | $459.42 ($272.07 – $594.37) · price is 1% above |
These figures come from the same calibrated model and valuation as the Amgen stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for AMGN
See the fair value, the probability range and the earnings history of Amgen on its ATLAS page.
Amgen (AMGN) stock analysisPlans from €3.99 a month.
Amgen earnings: frequently asked questions
When does Amgen (AMGN) report earnings?
Amgen is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AMGN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $5.74 per share (USD). Estimates can change before the report.
How often does AMGN beat earnings estimates?
Of its last 5 reports with a recorded result, Amgen beat the EPS estimate 5 times; the average surprise was +23.4%. Past results do not predict the next one.
How much does AMGN move around earnings?
Over its last 5 reports the stock moved an average of 5.9% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Amgen beat earnings estimates last quarter?
Amgen last reported on Aug 4, 2026: EPS of $6.29 against an estimate of $5.62 (+11.9% surprise), a beat.
How much does AMGN usually move in a day?
On a normal trading day the ATLAS model puts AMGN’s one-day range at about ±1.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer